Navigation Links
Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers
Date:11/12/2008

Awards Recognize Companies That Demonstrate Best Strategic Use of Mergers

and Acquisitions

ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- The Deal (http://www.thedeal.com) magazine has named Abbott (http://www.abbott.com)as the healthcare sector winner of its inaugural Most Admired Corporate Dealmakers Awards. The Deal honored Abbott for the most effective strategic use of acquisitions and divestitures.

Over the past decade, Abbott has reshaped its business portfolio with a focus on high-growth, innovation-driven businesses with market-leading potential. The company:

-- Acquired Knoll Pharmaceuticals, positioning Abbott as a global leader in biotechnology with HUMIRA(R), a biologic for treating several debilitating autoimmune diseases. Since its launch in 2003, HUMIRA has grown to more than $3 billion in annual sales in 2007 and Abbott expects sales of more than $4.4 billion in 2008.

-- Purchased Kos Pharmaceuticals (http://tinyurl.com/5t4tc4), immediately enhancing Abbott's existing franchise and portfolio strength in the $20 billion lipid management market.

-- Acquired Guidant's vascular business, (http://tinyurl.com/5jhjym) providing Abbott with the innovative drug-eluting stent, XIENCE V(TM) (http://tinyurl.com/5cwfns), and the world's first bioabsorbable drug-eluting stent (http://tinyurl.com/6pahst) to enter clinical trials. With nearly global availability since July 2008, XIENCE V has quickly gained market leadership based on strong clinical data.

-- Entered high-growth vascular and point-of-care markets through the acquisitions of Perclose and i-STAT and enhanced its leadership position in diabetes care with the purchase of TheraSense.

"Abbott has taken a deliberate approach to acquisitions, identifying and pursuing transactions that either complement our existing portfolio or allow us to enter new innovation-driven markets with leadership potential," said Miles D. White (http://tinyurl.com/5fa29a), chairman and chief executive officer, Abbott. "This strategic approach, combined with our internal R&D efforts, has enabled Abbott to consistently deliver industry-leading performance and generate double-digit returns for our shareholders."

The Deal's readers rated Abbott best on all four of its award criteria: choice of targets and strategy; price paid (or received) compared to value; execution, including integration; and overall quality of the deal team. Companies considered for the survey have a market capitalization of $5 billion or more as of June 30, 2008, and closed the highest number and dollar value of acquisitions and divestitures in the past three years.

About Abbott

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.

About The Deal LLC

The Deal LLC, (http://www.thedeal.com), is a diversified media company that is the authoritative voice of the deal economy. The Deal LLC serves the global deal community -- corporate and financial dealmakers, advisers and institutional investors -- by providing business and financial news and information that offers fresh insights on the deal economy, a set of interrelated activities, focused on dealmaking of all kinds, whose purpose is to generate corporate growth in a continually changing global market. The Deal LLC offers a comprehensive line of print and electronic products -- The Deal, The Daily Deal and TheDeal.com -- and live annual events including Private Capital Symposium, Distressed Investing Forum, Corporate Dealmaker Forum and M&A Outlook. The Deal LLC, a privately held company, is owned by private investment funds, including U.S. Equity Partners LP, sponsored by Wasserstein & Co. LP.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES ... has announced that Mercy Medical Center will serve as the official title sponsor of ... On Sunday, June 25, 2017, thousands of women will walk or run the course ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sublime Naturals ... "Spice of Life" or "Wonder Spice", it has been used for thousands of years. ... the East," says Heshelow, author of " Turmeric: How to Use it For Your ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... educational opportunities for attending prescribers at the upcoming World Congress, in Hollywood Florida ... has always been recognized as the visionary leader in the training of physicians, ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wall Centre Dental team ... patients from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, porcelain ... the esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, Milton ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... in Carnegie, OK, from Dr. Jamie Cameron, with or without a referral. ... to traditional orthodontic treatment. Depending on each patient’s case, treatment with the FASTBRACES ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... 2017  Spiral Therapeutics, Inc. today announced the ... S.L. for the worldwide exclusive rights to Bionure,s ... field of otolaryngology for aggregate payments of up ... agreement provides Spiral with the option to license ... profile. Under the terms of the agreement, Spiral ...
(Date:3/29/2017)... , March 29, 2017   Dynatronics Corporation ... the appointment of Cynthia L. McHenry ... be responsible for leading Dynatronics manufacturing, distribution, and ... report to Dynatronics, CEO Kelvyn H. Cullimore, ... an extensive search process conducted by the company ...
Breaking Medicine Technology: